Implementing an Electronic End-of-Life Chemotherapy Utilization Measure

Kraut J, Mooney K, Sweetenham JW, Page RD, Adelson K, Agarwala V, Fessele KL, Hamrick HJ, Kaganman I, Martineau J, Abernethy AP, and Meropol NJ

March 2019

Manuscript

Journal of Oncology Practice

Flatiron-authored

An evaluation of the impact of missing deaths on overall survival analyses of advanced non–small cell lung cancer patients conducted in an electronic health records database

Carrigan, G, Whipple, S, Taylor, MD, Torres, AZ, Gossai, A, Arnieri, B, Tucker, M, Hofmeister, PP, Lambert, P, Griffith, SD, Capra, WB

March 2019

Manuscript

Pharmacoepidemiology & Drug Safety

Flatiron-authored

Real-world trends in first-line checkpoint inhibitor use in advanced urothelial cell carcinoma

Parikh RB, Galsky MD, Baxi SS, Adamson B, Cohen AB, Feld E, Christodouleas JP, Boursi SB, Meropol NJ, Mamtani R

February 2019

Abstract

ASCO GU Symposium

Trends in checkpoint inhibitor therapy for advanced urothelial cell carcinoma at the end of life: Insights from real-world practice

Parikh RB, Galsky MD, Gyawali B, Riaz F, Kaufmann TL, Cohen AB, Adamson B, Gross CP, Meropol NJ, Mamtani R

February 2019

Abstract

ASCO GU Symposium

February 2019

Abstract

ASCO GU Symposium

February 2019

Abstract

ASCO GU Symposium

February 2019

Abstract

ASCO GU Symposium

February 2019

Abstract

ASCO GU Symposium

January 2019

Abstract

ASCO Gastrointestinal Cancers Symposium

January 2019

Abstract

ASCO GI Symposium

January 2019

Abstract

ASCO GI Symposium

Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval

Khozin S, Carson KR, Zhi J, Tucker M, Lee SE, Light DE, Curtis MD, Bralic M, Kaganman I, Gossai A, Hofmeister PP, Torres AZ, Miksad RA, Blumenthal GM, Pazdur R, Abernethy AP

December 2018

Manuscript

The Oncologist

Flatiron-authored

December 2018

Abstract

ESMO Immuno-Oncology Congress

December 2018

Manuscript

Current Medical Research and Opinion

Flatiron-authored

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

McGrath LJ, Hernandez RK, Overman R, Reams D, Liede A, Brookhart MA, O’Donnell E, Leah J

December 2018

Manuscript

Cancer Medicine

Influence of Prognostic Factors on Outcomes Among Metastatic Breast Cancer Patients Treated with CDK4&6 Inhibitors in Routine Clinical Practice

Saverno KR, Carter GC, Li L, Battiato LA, Huang Y-J, Smyth EN, Price GL, Sheffield KM, Baxi SS, Kuk D, Seidman AD

December 2018

San Antonio Breast Cancer Symposium

Flatiron-authored

December 2018

Abstract

San Antonio Breast Cancer Symposium

A real world evidence study of BRCA mutations and survival in HER2-negative breast cancer

Dalvi T, McLaurin K, Briceno J, Nordstrom B, Bennett J, Hettle R, Murphy B, Collins J, McCutcheon S

December 2018

Abstract

San Antonio Breast Cancer Symposium

December 2018

Abstract

San Antonio Breast Cancer Symposium

Real-world survival of heavily pretreated patients with refractory HR+, HER2- metastatic breast cancer receiving single-agent chemotherapy – A comparison with MONARCH 1

Rugo H, Dieras V, Cortes J, Patt D, Wildiers H, O'Shaughnessy J, Zamora E, Yardley DY, Carter GC, Sheffield KM, Li L, Andre VA, Derbyshire RE, Li XI, Frenzel M, Huang Y-J, Dickler MN, Tolaney SM

December 2018

Abstract

San Antonio Breast Cancer Symposium

December 2018

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2018

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2018

Abstract

American Society of Hematology Annual Meeting

Flatiron-authored

December 2018

Abstract

American Society of Hematology Annual Meeting

December 2018

Abstract

American Society of Hematology Annual Meeting

Treatment Patterns Among Adults with Newly Diagnosed Primary Immune Thrombocytopenia in the United States

Cetin K, McGrath L, Overman R, Reams D, Sharma A, Brookhart MA, Altomare I, Wasser JS

December 2018

Abstract

American Society of Hematology Annual Meeting

December 2018

Abstract

American Society of Hematology Annual Meeting

December 2018

Abstract

American Society of Hematology Annual Meeting

Comparative Efficacy Of Nivolumab±ipilimumab Versus Standard of Care (SOC) For Third-Line (3L) Patients with Recurrent Small Cell Lung Cancer (SCLC) Using Population-Adjusted Indirect Comparison

Cope S, Popoff E, Keeping S, Goldgrub R, Jansen JP, Penrod J, Abraham P, Camidge DR, Korytowsky B, Gu T, Schoenherr N, Juarez-Garcia A, Le T, Yuan Y

November 2018

Abstract

EU ISPOR

November 2018

Manuscript

Current Medical Research and Opinion

October 2018

Abstract

Society of Melanoma Research

October 2018

Abstract

Society of Melanoma Research

October 2018

Abstract

Society of Melanoma Research

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

Flatiron-authored

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

October 2018

Abstract

ESMO Annual Congress

ALK Testing Trends and Patterns Among Community Practices in the United States

Illei P, Wong W, Wu N, Chu L, Gupta R, Schulze K, Gubens M

October 2018

Manuscript

JCO Precision Oncology

Accelerating Anticancer Drug Development — Opportunities and Trade-offs

Nass S, Rothenberg M, Pentz R, Hricak H, Abernethy AP, Anderson K, Gee A, Harvey RD, Piantadosi S, Bertagnolli M, Schrag D, Schilsky R

October 2018

Manuscript

Nature Reviews Clinical Oncology

Flatiron-authored

September 2018

Manuscript

Future Medicine

Flatiron-authored

Distinctive Clinical Characteristics of SCLC in Never-Smokers

Mian I, Nichols S, Abernethy AP, Carson K, Maignan K, Torres AZ, Snider J, Frampton G, Li G, Sharon E, Szabo E, Thomas A

September 2018

Abstract

World Conference on Lung Cancer

Flatiron-authored

Sequencing of Ramucirumab+Docetaxel Postimmune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Clarke JM, Stefaniak VJ, Batus M, Winfree KB, Molife C, Cui Z, Han Y, Tawney MK, Bonomi PD

September 2018

Abstract

World Conference on Lung Cancer

Prognosis of Non-Driver, Never Smoker Metastatic Non-Small Lung Cancer (NSCLC)

Chalmers AW, Haaland B, Patel SB, Moynahan K, Cannon L, Akerley W

September 2018

Abstract

World Conference on Lung Cancer